Related Experiment Video
Updated: Jun 6, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Time to Progress Through the Latent Tuberculosis Infection Care Cascade in Primary Care
Angus Zhuo-Long Wu1, Kaylynn Aiona2, Matthew Murrill3
1Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Understanding the timing of latent tuberculosis infection (LTBI) care cascade steps is crucial for preventing tuberculosis disease. Patients progressing faster through LTBI treatment steps show better outcomes.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Control
Background:
- Latent tuberculosis infection (LTBI) treatment is key to preventing active tuberculosis disease.
- The LTBI care cascade framework identifies essential clinical steps for successful treatment.
- Characterizing the timing of LTBI care cascade progression is poorly understood.
Purpose of the Study:
- To calculate the timing of each step in the LTBI care cascade.
- To assess if timing influences progression through the LTBI care cascade.
Main Methods:
- Observational study using electronic health records (2020-2022, N=693,254 patients).
- Calculated median times for LTBI care cascade steps.
- Identified optimal maximum times (OMTs) using ROC curves.
- Compared cascade progression rates based on OMT adherence.
Main Results:
- Median LTBI care cascade completion time was 150 days.
- Key median times: test result (3 days), imaging order (7 days), treatment prescription (17 days), treatment start (0 days), treatment completion (116 days).
- Patients completing steps faster than OMTs had marginally higher cascade progression rates (RR 1.10-2.81).
Conclusions:
- Timely progression through the LTBI care cascade is associated with higher treatment success.
- Emphasizes the need for sustained follow-up and avoiding early 'lost to care' classification.
- Supports public health strategies focused on long-term patient engagement for LTBI treatment.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...